| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |